Hexagon Bio Closes $77.3M Series B Financing Round
The metagenome-focused drug discovery and computational biology company will look to advance oncology infectious disease research to the candidate nomination stage.
Agbio Gene Editing Firm Cibus to Merge With Plant Synbio Company Calyxt
The newly merged company will retain the Cibus name and trade on the Nasdaq Capital Market, where Calyxt is currently listed.
French DNA Data Storage Startup Biomemory Raises €5M in Seed Funding
The DNA synthesis and data storage company will use the funds to further optimize and reduce the cost of its technologies.
The firm plans to commercialize computational biology and machine learning technology developed to support Colossal's species conservation and "de-extincting" efforts.
Lesaffre Acquires Recombia Biosciences
The deal builds on a strategic partnership between the firms that started in 2020 to design and develop yeasts to produce fermented ingredients and biofuels.